Back to search results

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Clear Cell Renal Cell Carcinoma · Metastatic Clear Cell Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Brian A. Costello, MD)
Study leads

  • Brian A. Costello, MD

    Principal Investigator

    Mayo Clinic in Rochester

View source on ClinicalTrials.gov(opens in a new tab)